Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus.

Published online

Journal Article

BACKGROUND: Chronic obstructive pulmonary disease (COPD) has been classically divided into blue bloaters and pink puffers. The utility of these clinical subtypes is unclear. However, the broader distinction between airway-predominant and emphysema-predominant COPD may be clinically relevant. The objective was to define clinical features of emphysema-predominant and non-emphysematous COPD patients. METHODS: Current and former smokers from the Genetic Epidemiology of COPD Study (COPDGene) had chest computed tomography (CT) scans with quantitative image analysis. Emphysema-predominant COPD was defined by low attenuation area at -950 Hounsfield Units (LAA-950) ≥10%. Non-emphysematous COPD was defined by airflow obstruction with minimal to no emphysema (LAA-950 < 5%). RESULTS: Out of 4197 COPD subjects, 1687 were classified as emphysema-predominant and 1817 as non-emphysematous; 693 had LAA-950 between 5-10% and were not categorized. Subjects with emphysema-predominant COPD were older (65.6 vs 60.6 years, p < 0.0001) with more severe COPD based on airflow obstruction (FEV1 44.5 vs 68.4%, p < 0.0001), greater exercise limitation (6-minute walk distance 1138 vs 1331 ft, p < 0.0001) and reduced quality of life (St. George's Respiratory Questionnaire score 43 vs 31, p < 0.0001). Self-reported diabetes was more frequent in non-emphysematous COPD (OR 2.13, p < 0.001), which was also confirmed using a strict definition of diabetes based on medication use. The association between diabetes and non-emphysematous COPD was replicated in the ECLIPSE study. CONCLUSIONS: Non-emphysematous COPD, defined by airflow obstruction with a paucity of emphysema on chest CT scan, is associated with an increased risk of diabetes. COPD patients without emphysema may warrant closer monitoring for diabetes, hypertension, and hyperlipidemia and vice versa. TRIAL REGISTRATION: Clinicaltrials.gov identifiers: COPDGene NCT00608764, ECLIPSE NCT00292552.

Full Text

Duke Authors

Cited Authors

  • Hersh, CP; Make, BJ; Lynch, DA; Barr, RG; Bowler, RP; Calverley, PMA; Castaldi, PJ; Cho, MH; Coxson, HO; DeMeo, DL; Foreman, MG; Han, MK; Harshfield, BJ; Hokanson, JE; Lutz, S; Ramsdell, JW; Regan, EA; Rennard, SI; Schroeder, JD; Sciurba, FC; Steiner, RM; Tal-Singer, R; van Beek, E; Silverman, EK; Crapo, JD; COPDGene and ECLIPSE Investigators,

Published Date

  • October 24, 2014

Published In

Volume / Issue

  • 14 /

Start / End Page

  • 164 -

PubMed ID

  • 25341556

Pubmed Central ID

  • 25341556

Electronic International Standard Serial Number (EISSN)

  • 1471-2466

Digital Object Identifier (DOI)

  • 10.1186/1471-2466-14-164

Language

  • eng

Conference Location

  • England